Gene Therapy Induces Antigen-Specific Tolerance in Experimental Collagen-Induced Arthritis
- PMID: 27159398
- PMCID: PMC4861286
- DOI: 10.1371/journal.pone.0154630
Gene Therapy Induces Antigen-Specific Tolerance in Experimental Collagen-Induced Arthritis
Abstract
Here, we investigate induction of immunological tolerance by lentiviral based gene therapy in a mouse model of rheumatoid arthritis, collagen II-induced arthritis (CIA). Targeting the expression of the collagen type II (CII) to antigen presenting cells (APCs) induced antigen-specific tolerance, where only 5% of the mice developed arthritis as compared with 95% of the control mice. In the CII-tolerized mice, the proportion of Tregs as well as mRNA expression of SOCS1 (suppressors of cytokine signaling 1) increased at day 3 after CII immunization. Transfer of B cells or non-B cell APC, as well as T cells, from tolerized to naïve mice all mediated a certain degree of tolerance. Thus, sustainable tolerance is established very early during the course of arthritis and is mediated by both B and non-B cells as APCs. This novel approach for inducing tolerance to disease specific antigens can be used for studying tolerance mechanisms, not only in CIA but also in other autoimmune diseases.
Conflict of interest statement
Figures





References
-
- Michaelsson E, Andersson M, Engstrom A, Holmdahl R Identification of an immunodominant type-II collagen peptide recognized by T cells in H-2q mice: self tolerance at the level of determinant selection. Eur J Immunol 1992. 22: 1819 - PubMed
-
- Brunsberg U, Gustafsson K, Jansson L, Michaelsson E, Ahrlund-Richter L, Pettersson S, et al. Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis. Eur J Immunol 1994. 24: 1698 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical